Report: More than half of the world's population will be overweight/obese by 2035

Published Date: 08 Mar 2023

The World Health Organization's 2023 Atlas predicts that 51% of the world's population, or more than 4 billion people, will be overweight or obese within the next 12 years.

Read Full News

Latest News

Rhythm's Drug Shows Promise for Brain Tumor-related Weight Condition in Small Study

Rhythm Pharmaceuticals said on Tuesday its experimental weekly injectable drug helped reduce body weight in ⁠patients with a rare form of obesity caused by damage to the...

Retatrutide Expanded Access Draws Mixed Clinician Views

Lilly expands access to unapproved retatrutide for selected patients, but some clinicians anticipate an ‘avalanche’ of requests.

Tumor Volume Tied to Hormonal Decline Post-Pituitary Surgery

Patients with larger non-functioning pituitary adenomas face greater hormonal deterioration after transsphenoidal surgery, while complete tumor removal appears protective.

GLP-1 Drugs May Reshape, Not Replace, Bariatric Surgery

At ICO 2026, specialists said bariatric surgery will remain important in severe obesity, even as GLP-1 drugs expand treatment options before and after surgery.

Novo Nordisk Wins Dutch Court Injunction in Semaglutide Patent Infringement Case

Novo Nordisk said on ⁠Wednesday it had won a preliminary ⁠injunction against Ceban Ziekenhuisfarmacie from ⁠a district court ‌in the Netherlands in a patent infringement...

Photo-Based Meal Apps Underestimate Calories and Fat

AI-powered, photo-based meal-tracking apps underestimate calorie content by roughly a third and fat content by about 30 g per meal, and some also underestimate carbohydrates.

Todays Updates

Gatekeeping May Reduce Pediatric Cancer Trial Participation

Researchers query parents of children with cancer and clinicians on barriers and facilitators to participation in clinical trials.

AI Framework Helps Classify Renal Tumors, Predict Outcomes

A deep learning system trained on whole-slide images classifies nine renal tumor subtypes with high accuracy and outperforms traditional grading in predicting patient outcomes.

Todays Updates

Gatekeeping May Reduce Pediatric Cancer Trial Participation

Researchers query parents of children with cancer and clinicians on barriers and facilitators to participation in clinical trials.

AI Framework Helps Classify Renal Tumors, Predict Outcomes

A deep learning system trained on whole-slide images classifies nine renal tumor subtypes with high accuracy and outperforms traditional grading in predicting patient outcomes.

Latest News

Rhythm Pharmaceuticals said on Tuesday its experimental weekly injectable drug helped reduce body weight in ⁠patients with a rare form of obesity caused by damage to the...

Lilly expands access to unapproved retatrutide for selected patients, but some clinicians anticipate an ‘avalanche’ of requests.

Patients with larger non-functioning pituitary adenomas face greater hormonal deterioration after transsphenoidal surgery, while complete tumor removal appears protective.

At ICO 2026, specialists said bariatric surgery will remain important in severe obesity, even as GLP-1 drugs expand treatment options before and after surgery.

Novo Nordisk said on ⁠Wednesday it had won a preliminary ⁠injunction against Ceban Ziekenhuisfarmacie from ⁠a district court ‌in the Netherlands in a patent infringement...

AI-powered, photo-based meal-tracking apps underestimate calorie content by roughly a third and fat content by about 30 g per meal, and some also underestimate carbohydrates.

News All Time

Body Fat Beats BMI in Predicting Fracture Risk on AI Therapy

For women taking aromatase inhibitors for early-stage breast cancer, a high body fat percentage may raise the risk for vertebral fracture, regardless of BMI.

Sleep Coaching May Benefit Some Adults With T1D

In adults with T1D and short or irregular sleep, 12 weeks of sleep coaching via phone can improve sleep, ease diabetes-related stress, and lower blood sugar in those with suboptimal A1c levels.

Novel Oral GLP-1 Agonist Boosts Glycemic Control in T2D

In patients with type 2 diabetes inadequately controlled with metformin, adding a novel nonpeptide oral GLP-1 receptor agonist to metformin boosts glycemic control.

Lower Income Affects Pancreatic Cancer Tx, Survival

Lower household income is linked to less treatment and worse survival in patients with localised pancreatic adenocarcinoma, a Dutch study shows.

Who 'Owns' Long-Term TED Management in the Biologic Era?

Targeted biologics and multidisciplinary care are reshaping the management of patients with thyroid eye disease. But who should be leading this care and how? Medscape would like to hear from you about how often you see TED, your biggest clinical challenges, and which treatments you rely on most.

Remote HIIT Sustains Weight Loss in Adolescents

A remotely supervised high-intensity interval training program helped adolescents with obesity lose weight and improve fitness, with benefits lasting at least a year after sessions ended.

Machine Learning Model Boosts Genetic Prediction of T1D Risk

A machine learning model improves prediction of type 1 diabetes risk compared with a conventional genetic risk model, particularly in people without high-risk human leukocyte antigen haplotypes.

Rising, Falling Fat Mass Both Move Endotrophin Levels

Circulating endotrophin rises with fat gain and falls with fat loss, showing promise as a biomarker of body fat changes and a potential target for reducing obesity-linked health risks.

When Temperatures Climb, Hypoglycemia Risk Rises in T1D

An analysis of nearly 33 million continuous glucose monitoring readings links hotter temperatures to more frequent hypoglycemia in adults with type 1 diabetes.

Physical Activity Boosts Self-Esteem in Obesity

Women with obesity who completed supervised physical activity programs — whether face-to-face or digital — showed marked improvements in self-esteem and body image, with most gains emerging in the first month and persisting 3 months later.

Brazil Greenlights Five New Injectable Diabetes Drugs

Brazil's health regulator said ⁠it approved five new injectable GLP-1 drugs for diabetes and obesity treatment, ⁠following the expiration ⁠of Ozempic’s patent in ‌the country.

Statement Offers Guidance Around Incretin Prescribing

Consensus document from three European societies covers nutritional, functional, and psychological considerations for incretin-based therapies in adults.

T1D Onset Before Age 10 Tied to Higher Dementia Risk

Individuals with T1D diagnosed before the age of 10 years face a higher risk of developing dementia than those diagnosed later between ages of 18 and 30 years, a Swedish nationwide study shows.

Urinary Incontinence May Lower Exercise Intensity in Women

More than 75% of women in a UK survey reported urinary incontinence, with those experiencing more severe symptoms engaging in less vigorous physical activity, study finds.

Yo-Yo Dieting Accelerates Muscle Loss in Middle Age

Repeated episodes of weight loss and regain may be associated with a greater loss of muscle volume than keeping weight stable.

ART Regimen Drives Metabolic Variation in Pediatric HIV

The specific antiretroviral therapy regimen—not just HIV status—profoundly shapes the metabolic landscape in virally suppressed children living with HIV.

Recommended News For You

Ineffective medication can remove the "worst fear" of schizophrenia.

More pain, more gain? New biopsy technique found to improve prostate cancer detection

Trial Challenges Indefinite Maintenance for Multiple Myeloma

In NPM1-mutated acute myeloid leukemia, MRD Correlates with Allo-Transplant Benefit.

Why alarm is easing over a rise in pancreatic cancer among the young

Real World CAR T-Cell Therapy Outcomes 'Favorable' in Relapsed/Refractory Myeloma

3D virtual staining technology enables non-invasive observation of cancer tissue

Recommended Articles For You

The Journey Beyond Treatment: Empowering Cancer Survivorship with Technology and Artificial Intelligence 

The Future of Oncology: Innovations Every Doctor Should Know 

Building Bridges between Heart and Cancer Care: A Comprehensive Guide to Cardio-Oncology Clinics 

The New Era of Oncology: Key Updates and Clinical Insights 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Applications are being accepted for TN Health's post-doctoral fellowship program in gynecologic oncology and minimal access surgery; complete details are available here.

2.

A Win for Molecularly Guided Therapy for Cancer of Unknown Primary

3.

PSMA PET Beats MRI in Prostate Cancer Staging Study

4.

Global warming could be driving up women's cancer risk, find researchers

5.

Traces of bacteria inside brain tumors may affect tumor behavior

1.

Unlocking the Power of Hematocrit: Exploring the Benefits of Blood Cell Counts

2.

Multiple Myeloma: Understanding the Basics 

3.

Hematopoietic Stem Cell Fitness Biomarkers: Clinical Relevance and Emerging Paradigms

4.

Targeted Therapies for Breast Cancer: What’s New?

5.

How Bispecific Antibodies are Redefining Medical Oncology in the US - A 2025 Review

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

1.

A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

2.

The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.

3.

Clinical Excellence in Hematology

4.

Emerging Concepts in Hematology

5.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot